MPN-话题@MedSci

#MPN#

9篇内容 | 1113人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2205696, encodeId=4f552205696a2, content=<a href='/topic/show?id=c15f10196028' target=_blank style='color:#2F92EE;'>#骨髓增殖性肿瘤#</a> <a href='/topic/show?id=4302121e605' target=_blank style='color:#2F92EE;'>#MPN#</a>, objectTitle=Blood Adv：加速期/急变期骨髓增殖性肿瘤的当代治疗及结局, objectType=article, longId=826697, objectId=11e482669e31, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240520/1716188081417_5579292.jpg, objectUrl=/article/show_article.do?id=11e482669e31, replyNumber=0, likeNumber=50, createdTime=2024-05-20, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=11e482669e31, moduleTitle=Blood Adv：加速期/急变期骨髓增殖性肿瘤的当代治疗及结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11e482669e31)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1935501, encodeId=6075193550178, content=<a href='/topic/show?id=4302121e605' target=_blank style='color:#2F92EE;'>#MPN#</a>, objectTitle=【Blood Adv】羟基脲治疗老年经典型MPN，不增加第二恶性肿瘤风险, objectType=article, longId=735271, objectId=3adbe352718e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3adbe352718e, replyNumber=0, likeNumber=0, createdTime=2023-02-13, rootId=0, userName=12498568m50暂无昵称, userId=1e452500029, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3adbe352718e, moduleTitle=【Blood Adv】羟基脲治疗老年经典型MPN，不增加第二恶性肿瘤风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3adbe352718e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1935499, encodeId=cf231935499ee, content=<a href='/topic/show?id=4302121e605' target=_blank style='color:#2F92EE;'>#MPN#</a>, objectTitle=Blood：MDS/MPN不同亚型的遗传异质性, objectType=article, longId=196875, objectId=78f11968e54e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78f11968e54e, replyNumber=0, likeNumber=85, createdTime=2020-11-21, rootId=0, userName=12498568m50暂无昵称, userId=1e452500029, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78f11968e54e, moduleTitle=Blood：MDS/MPN不同亚型的遗传异质性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78f11968e54e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1935498, encodeId=eb3f1935498f0, content=<a href='/topic/show?id=4302121e605' target=_blank style='color:#2F92EE;'>#MPN#</a>, objectTitle=Blood：CALR单倍剂量不足可增强造血干细胞的活性，参与MPN的发生, objectType=article, longId=191283, objectId=9ad8191283ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ad8191283ef, replyNumber=0, likeNumber=104, createdTime=2021-01-18, rootId=0, userName=12498568m50暂无昵称, userId=1e452500029, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ad8191283ef, moduleTitle=Blood：CALR单倍剂量不足可增强造血干细胞的活性，参与MPN的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ad8191283ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1935500, encodeId=3824193550002, content=<a href='/topic/show?id=4302121e605' target=_blank style='color:#2F92EE;'>#MPN#</a>, objectTitle=Blood：造血细胞高表达CXCL4促进MPN骨髓纤维化进展, objectType=article, longId=198806, objectId=c7d1198806a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7d1198806a6, replyNumber=0, likeNumber=0, createdTime=2020-11-09, rootId=0, userName=12498568m50暂无昵称, userId=1e452500029, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7d1198806a6, moduleTitle=Blood：造血细胞高表达CXCL4促进MPN骨髓纤维化进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7d1198806a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1935497, encodeId=e538193549e65, content=<a href='/topic/show?id=4302121e605' target=_blank style='color:#2F92EE;'>#MPN#</a>, objectTitle=Blood：MPN患者动脉血栓栓塞提示继发癌症, objectType=article, longId=185277, objectId=5d251852e789, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d251852e789, replyNumber=0, likeNumber=64, createdTime=2020-02-16, rootId=0, userName=12498568m50暂无昵称, userId=1e452500029, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d251852e789, moduleTitle=Blood：MPN患者动脉血栓栓塞提示继发癌症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d251852e789)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1935496, encodeId=202f19354966d, content=<a href='/topic/show?id=4302121e605' target=_blank style='color:#2F92EE;'>#MPN#</a>, objectTitle=Blood：JAK2突变型造血细胞的代谢变化可作为MPN的治疗靶点, objectType=article, longId=179590, objectId=f88b1e959038, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f88b1e959038, replyNumber=0, likeNumber=78, createdTime=2019-10-25, rootId=0, userName=12498568m50暂无昵称, userId=1e452500029, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f88b1e959038, moduleTitle=Blood：JAK2突变型造血细胞的代谢变化可作为MPN的治疗靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f88b1e959038)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1935495, encodeId=9e1a193549592, content=<a href='/topic/show?id=4302121e605' target=_blank style='color:#2F92EE;'>#MPN#</a>, objectTitle=IJLH：应重新评估将难治性贫血作为MDS/MPN‐RS‐T诊断标准的要求？, objectType=article, longId=175935, objectId=6da11e593555, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6da11e593555, replyNumber=0, likeNumber=73, createdTime=2019-10-06, rootId=0, userName=12498568m50暂无昵称, userId=1e452500029, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6da11e593555, moduleTitle=IJLH：应重新评估将难治性贫血作为MDS/MPN‐RS‐T诊断标准的要求？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6da11e593555)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1935494, encodeId=8042193549442, content=<a href='/topic/show?id=4302121e605' target=_blank style='color:#2F92EE;'>#MPN#</a>, objectTitle=Blood：用JAK1/2抑制剂治疗骨髓增生性肿瘤（MPN）可增加患者恶性B细胞淋巴瘤的发病率, objectType=article, longId=141010, objectId=cb7914101089, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb7914101089, replyNumber=0, likeNumber=0, createdTime=2019-04-26, rootId=0, userName=12498568m50暂无昵称, userId=1e452500029, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb7914101089, moduleTitle=Blood：用JAK1/2抑制剂治疗骨髓增生性肿瘤（MPN）可增加患者恶性B细胞淋巴瘤的发病率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb7914101089)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1935493, encodeId=0924193549367, content=<a href='/topic/show?id=4302121e605' target=_blank style='color:#2F92EE;'>#MPN#</a>, objectTitle=Blood：造血干细胞Srsf2[P95H]突变启动髓系偏倚和骨髓增生异常/骨髓及髓外增生异常（MDS/MPN）综合征, objectType=article, longId=140939, objectId=c0ea140939f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0ea140939f3, replyNumber=0, likeNumber=0, createdTime=2018-08-21, rootId=0, userName=12498568m50暂无昵称, userId=1e452500029, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0ea140939f3, moduleTitle=Blood：造血干细胞Srsf2[P95H]突变启动髓系偏倚和骨髓增生异常/骨髓及髓外增生异常（MDS/MPN）综合征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0ea140939f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

MPN

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#骨髓增殖性肿瘤# #MPN#

Blood Adv：加速期/急变期骨髓增殖性肿瘤的当代治疗及结局

2024-05-20发表于上海

12498568m50暂无昵称 (审核中...)

前往app查看评论内容

#MPN#

【Blood Adv】羟基脲治疗老年经典型MPN，不增加第二恶性肿瘤风险

2023-02-13

12498568m50暂无昵称 (审核中...)

前往app查看评论内容

#MPN#

Blood：MDS/MPN不同亚型的遗传异质性

2020-11-21

12498568m50暂无昵称 (审核中...)

前往app查看评论内容

#MPN#

Blood：CALR单倍剂量不足可增强造血干细胞的活性，参与MPN的发生

2021-01-18

12498568m50暂无昵称 (审核中...)

前往app查看评论内容

#MPN#

Blood：造血细胞高表达CXCL4促进MPN骨髓纤维化进展

2020-11-09

12498568m50暂无昵称 (审核中...)

前往app查看评论内容

#MPN#

Blood：MPN患者动脉血栓栓塞提示继发癌症

2020-02-16

12498568m50暂无昵称 (审核中...)

前往app查看评论内容

#MPN#

Blood：JAK2突变型造血细胞的代谢变化可作为MPN的治疗靶点

2019-10-25

12498568m50暂无昵称 (审核中...)

前往app查看评论内容

#MPN#

IJLH：应重新评估将难治性贫血作为MDS/MPN‐RS‐T诊断标准的要求？

2019-10-06

12498568m50暂无昵称 (审核中...)

前往app查看评论内容

#MPN#

Blood：用JAK1/2抑制剂治疗骨髓增生性肿瘤（MPN）可增加患者恶性B细胞淋巴瘤的发病率

2019-04-26

12498568m50暂无昵称 (审核中...)

前往app查看评论内容

#MPN#

Blood：造血干细胞Srsf2[P95H]突变启动髓系偏倚和骨髓增生异常/骨髓及髓外增生异常（MDS/MPN）综合征

2018-08-21

科室
- - 订阅+
  - 更多科室
工具
服务